"Insulin Antagonists" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds which inhibit or antagonize the biosynthesis or action of insulin.
| Descriptor ID |
D007329
|
| MeSH Number(s) |
D06.347.420 D27.505.696.399.450.420
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Insulin Antagonists".
Below are MeSH descriptors whose meaning is more specific than "Insulin Antagonists".
This graph shows the total number of publications written about "Insulin Antagonists" by people in this website by year, and whether "Insulin Antagonists" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 1 | 0 | 1 |
| 2008 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Insulin Antagonists" by people in Profiles.
-
Sch?ffer L, Brand CL, Hansen BF, Ribel U, Shaw AC, Slaaby R, Sturis J. A novel high-affinity peptide antagonist to the insulin receptor. Biochem Biophys Res Commun. 2008 Nov 14; 376(2):380-3.
-
Klover PJ, Zimmers TA, Koniaris LG, Mooney RA. Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice. Diabetes. 2003 Nov; 52(11):2784-9.